Naloxone's pentapeptide binding site on filamin A blocks Mu opioid receptor-Gs coupling and CREB activation of acute morphine
about
Ser/ Thr residues at α3/β5 loop of Gαs are important in morphine-induced adenylyl cyclase sensitization but not mitogen-activated protein kinase phosphorylationHuman abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.Nanoscale effects of ethanol and naltrexone on protein organization in the plasma membrane studied by photoactivated localization microscopy (PALM).Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91phox subunit of NADPH oxidasePharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4Complex roles of filamin-A mediated cytoskeleton network in cancer progression.Ultralow Dose of Naloxone as an Adjuvant to Intrathecal Morphine Infusion Improves Perceived Quality of Sleep but Fails to Alter Persistent Pain: A Randomized, Double-blind, Controlled Study.Evidence from basic research for opioid combinations.Opioid antagonists for pain.Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4.Glial dysfunction and persistent neuropathic postsurgical pain.Contribution of adrenomedullin to the switch of G protein-coupled μ-opioid receptors from Gi to Gs in the spinal dorsal horn following chronic morphine exposure in rats.Spatio-temporal profiling of Filamin A RNA-editing reveals ADAR preferences and high editing levels outside neuronal tissues.The stereoisomer (+)-naloxone potentiates G-protein coupling and feeding associated with stimulation of mu opioid receptors in the parabrachial nucleus.Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjects.
P2860
Q24300079-D67790E0-DEF9-426F-B3CF-A775D0586CCDQ33884718-591B8CCB-F5E7-4EAB-8527-E03D2615E348Q35087610-4B87EAAE-034D-493B-8C4A-EDBD53956E18Q35833987-C1315A1F-E725-4250-A760-35A4AF2D3D8BQ36599638-C16799C8-01C7-4400-8678-BFCB46EAFFD3Q36614195-D1A19C47-1312-40B6-82E6-536DB47CF31DQ36973386-DED9C7A8-D848-4BA1-8D9D-6E4A68A4FF3AQ37999097-285363C1-1338-48C8-87C8-0DA9BAEF37A6Q38088778-02777601-ED84-43FE-83CE-47123097878EQ38506636-E8616CD2-C6E8-4CD9-A0F3-5DDB5C2B1F9AQ39210606-34C3CED8-84E0-4A30-B79D-60AD4A660E3EQ42099574-0C0FF4E2-90F1-45EE-BABA-50A5FC909B3BQ42788896-D54839F6-72D4-4853-BB7F-0444C606EE50Q44337706-E122C708-852A-4738-986D-8AEAF58FBE33Q49074804-80383D51-BF6B-4D4E-9EE0-7F0B0FFD012C
P2860
Naloxone's pentapeptide binding site on filamin A blocks Mu opioid receptor-Gs coupling and CREB activation of acute morphine
description
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique PLoS ONE
@fr
artículu científicu espublizáu en 2009
@ast
im Januar 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/01/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/01/01)
@nl
наукова стаття, опублікована в січні 2009
@uk
name
Naloxone's pentapeptide bindin ...... B activation of acute morphine
@ast
Naloxone's pentapeptide bindin ...... B activation of acute morphine
@en
Naloxone's pentapeptide bindin ...... B activation of acute morphine
@nl
type
label
Naloxone's pentapeptide bindin ...... B activation of acute morphine
@ast
Naloxone's pentapeptide bindin ...... B activation of acute morphine
@en
Naloxone's pentapeptide bindin ...... B activation of acute morphine
@nl
prefLabel
Naloxone's pentapeptide bindin ...... B activation of acute morphine
@ast
Naloxone's pentapeptide bindin ...... B activation of acute morphine
@en
Naloxone's pentapeptide bindin ...... B activation of acute morphine
@nl
P2860
P1433
P1476
Naloxone's pentapeptide bindin ...... B activation of acute morphine
@en
P2093
Hoau-Yan Wang
Lindsay H. Burns
P2860
P356
10.1371/JOURNAL.PONE.0004282
P407
P577
2009-01-01T00:00:00Z